BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Histology Image Analysis Provider OracleBio to Showcase Their Xenograft Evaluation Services at the Tumor Models Conference, Boston, MA


7/23/2013 9:21:31 AM

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Newhouse, Scotland, July 23 / B3C newswire / - OracleBio, providers of high precision digital image analysis services for detailed quantification of histological marker staining within cells and tissues, is pleased to announce it will be a principal sponsor of the forthcoming Tumor Models conference to be held in Boston, MA on the 23-25th July.

At the conference OracleBio’s Chief Scientific Officer, Dr Lorcan Sherry, will also deliver a presentation entitled ‘Detailed Quantification of Drug Response Read-outs in Tumor Xenograft Tissue using Whole Slide Digital Image Analysis’, which will highlight OracleBio’s expertise in using Definiens Tissue Studio™ for quantification of common Xenograft drug efficacy parameters.

Using state of the art Definiens image analysis software, OracleBio can deliver accurate and consistent quantification of histological, IHC and ISH marker staining on a cell-by-cell basis. The company have extensive experience of tumor xenograft analysis, covering a wide range of drug response read-outs including viable and necrotic content, mechanistic markers (proliferation, microvessel density, apoptosis, DNA damage and more) and specific biomarker expression within sub-cellular compartments (nucleus, cytoplasm and membrane).

“Our client base now includes some of the world’s largest pharmaceutical companies,” explains Dr John Waller, COO of OracleBio ”and with over 75 years’ management experience of working within Pharma R&D, biomarker research and image analysis, OracleBio brings a wealth of expertise and value to its customers by combining scientific excellence and Definiens image analysis solutions”.

Dr Sherry continues “Our customers clearly benefit from the high data quality and fast turn-around times we can deliver using Definiens Tissue Studio™, which is considered the industry gold standard image analysis software”.

OracleBio’s success is reflected in a recent expansion of its workforce to include two new business development managers based in the USA and Europe, who aim to enhance the provision of image analysis services within Pharma R&D, diagnostics development, digital pathology and biomarker research.



About OracleBio

OracleBio provides high precision image analysis services for quantification of protein and RNA in cells and tissues. Using Definiens’ state of the art Tissue Studio™ software (www.definiens.com), OracleBio delivers accurate and detailed quantification of nuclear, membrane and cytoplasmic markers on a cell-by-cell basis within whole slide, or single field of view images from chromogenic and fluorescent stained cells and tissues.

Contact

Dr Lorcan Sherry

Tel: +44(0) 141 2550252

lorcan.sherry@oraclebio.com

Help employers find you! Check out all the jobs and post your resume.


Read at BioSpace.com

 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES